DPIIT recognised startup Government of India
Startup India
Rekin Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.53 Cr
▲ 10% YoY
Net profit · FY 2025
₹5.34 Lakh
Net margin 1.5%
EBITDA · FY 2025
₹16.81 Lakh
EBITDA margin 4.8%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹11 Lakh
Issued & subscribed
Open charges
₹76 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
4
As per MCA filings
About Rekin Pharma Private Limited
Data last updated:
Rekin Pharma Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC313924. Its GSTIN is 07AAICR1573J1Z4 (Delhi).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors including Sunil Kumar Aggarwal (Managing Director) and Rohan Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Wz 32 33 Main Road Sadh Nagar Palam Colony, New Delhi, Delhi, India – 110045.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.53 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹5.34 Lakh (net margin 1.5%) and EBITDA of ₹16.81 Lakh (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years.
The company is associated with 1 brand: Rekin Pharma. As per MCA filings, the company has open charges of ₹76 Lakh on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it.
Rekin Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0011280). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rekinpharma.in.
Company details
CIN U74999DL2017PTC313924
Registration Number 313924
Incorporation Date 06 March 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0011280
Recognitions & Rankings of Rekin Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-10-0011280
Contact details
Rekin Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is rekinpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressWz 32 33 Main Road Sadh Nagar Palam Colony, New Delhi, Delhi, India – 110045
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rekin Pharma Private Limited, buy the company report.
Comprehensive company report
Rekin Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Rekin Pharma operates one associated brand: Rekin Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution of medical products in India. | rekinpharma.in |
Business activity
The main business activity of Rekin Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Rekin Pharma Private Limited, buy the company report.
Financials of Rekin Pharma Private Limited
FY 2024 filings availableRekin Pharma Private Limited reported revenue of ₹3.53 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹3.53 Cr ▲ 10%
Net profit · FY 2025
₹5.34 Lakh margin 1.5%
EBITDA · FY 2025
₹16.81 Lakh margin 4.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 269%
5 years · compounded
▲ 99%
Revenue has grown at a compounded annual rate (CAGR) of 20% over three years, including 10% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rekin Pharma Private Limited, buy the company report.
Board of directors of Rekin Pharma Private Limited
Rekin Pharma has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohan Aggarwal | Director | 06 Mar 2017 | 9 Years 7 Months | Current |
| Ritik Aggarwal | Director | 06 Mar 2017 | 9 Years 7 Months | Current |
| Rekha Aggarwal | Director | 06 Mar 2017 | 9 Years 7 Months | Current |
| Sunil Kumar Aggarwal | Managing Director | 06 Mar 2017 | 9 Years 7 Months | Current |
Auditor
Rekin Pharma Private Limited is audited by KOHLI GARG AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KOHLI GARG AND ASSOCIATES | FY 2023 | 023606N |
Shareholding
The shareholding of Rekin Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rekin Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹76 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jun 2023 | 100737640 | Others | ₹76 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Rekin Pharma Private Limited has 5 court cases on record: 2 filed by Rekin Pharma, 3 filed against it. All cases are disposed.
Total cases
5
Filed by the company
2
Filed against the company
3
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 2 | 0 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Rexcin Pharmaceuticals Pvt. Ltd. | Disposed |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed against the company by Rexcin Pharmaceuticals P Ltd | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against Rexcin Pharmaceuticals Pvt Ltd and Anr | Disposed |
| District court, South West, Delhi | Court case (CS DJ ADJ) | Filed by the company against Rexcin Pharmaceuticals Pvt Ltd Through Its Director Sh.Satinder Pal Singh and 2 others | Disposed |
| District court, New Delhi, Delhi | Criminal case | Filed against the company by Weights and Measures Department | Disposed |
To see the full case history of Rekin Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rekin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rekin Pharma Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
Active EPFO establishments
1
GST
Rekin Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICR1573J1Z4 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rekin Pharma Private Limited, buy the company report.
Recent activity
Rekin Pharma Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Rekha Aggarwal was appointed as Director on 06 Mar 2017.
AGM
Rekin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rekin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 76.00 Lakh with Charge ID 100737640 was registered on 21 Jun 2023.
Appointed
Rekha Aggarwal was appointed as Director.
Appointed
Ritik Aggarwal was appointed as Director.
Appointed
Rohan Aggarwal was appointed as Director.
Appointed
Sunil Kumar Aggarwal was appointed as Managing Director.
Incorporation
06 Mar 2017
Rekin Pharma Private Limited was registered on 06 Mar 2017 with Roc Delhi & aged 9 years 7 months as per MCA records.
Frequently asked questions
Rekin Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 March 2017 (9+ years old) and is registered under CIN U74999DL2017PTC313924.
Rekin Pharma has 4 current directors:
- Sunil Kumar Aggarwal - Managing Director
- Rohan Aggarwal - Director
- Ritik Aggarwal - Director
- Rekha Aggarwal - Director
The latest financial statements of Rekin Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Rekin Pharma is 07AAICR1573J1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Rekin Pharma is U74999DL2017PTC313924. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rekin Pharma has 5 court cases on record: 2 filed by the company and 3 filed against it. Most are in the high courts.
Rekin Pharma was incorporated on 06 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Rekha Aggarwal was appointed as Director on 06 Mar 2017. Ritik Aggarwal was appointed as Director on 06 Mar 2017. Rohan Aggarwal was appointed as Director on 06 Mar 2017. Rekin Pharma has 4 board changes on record in total.
Yes, Rekin Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Rekin Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0011280).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages